Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study.
作者信息
Crodel Carl C, Jentsch-Ullrich Kathleen, Koschmieder Steffen, Kämpfe Dietrich, Griesshammer Martin, Döhner Konstanze, Jost Philipp J, Wolleschak Denise, Isfort Susanne, Stegelmann Frank, Jilg Stefanie, Hofmann Verena, Auteri Guiseppe, Rachow Tobias, Ernst Philipp, Brioli Annamaria, von Lilienfeld-Toal Marie, Hochhaus Andreas, Palandri Francesca, Heidel Florian H
机构信息
Innere Medizin 2, Hämatologie und Onkologie, Universitätsklinikum Jena, Jena, Germany.
Gemeinschaftspraxis Hämatologie und Onkologie, Magdeburg, Germany.
出版信息
Leukemia. 2020 Jul;34(7):1949-1953. doi: 10.1038/s41375-020-0890-1. Epub 2020 May 30.
Abstract
摘要
相似文献
1
Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study.948例骨髓增殖性肿瘤患者的感染频率：一项前瞻性多中心患者报告的试点研究。
Leukemia. 2020 Jul;34(7):1949-1953. doi: 10.1038/s41375-020-0890-1. Epub 2020 May 30.
2
Item nonresponse on the Myeloproliferative Neoplasms Symptom Assessment Form (MPN-SAF): a comparison of missing data strategies.骨髓增殖性肿瘤症状评估表（MPN-SAF）中的项目未应答：缺失数据策略的比较。
Leuk Lymphoma. 2019 Jul;60(7):1789-1795. doi: 10.1080/10428194.2018.1548705. Epub 2019 Jan 17.
3
Risk of infections in patients with myeloproliferative neoplasms-a population-based cohort study of 8363 patients.骨髓增殖性肿瘤患者的感染风险：一项基于人群的 8363 例患者的队列研究。
Leukemia. 2021 Feb;35(2):476-484. doi: 10.1038/s41375-020-0909-7. Epub 2020 Jun 16.
4
Outcomes research and obstructive sleep apnea.结果研究与阻塞性睡眠呼吸暂停。
Laryngoscope. 2000 Mar;110(3 Pt 3):16-20. doi: 10.1097/00005537-200003002-00005.
5
Challenges of patients with myeloproliferative neoplasms (MPN) in times of COVID: First results from a patient survey by the German Study Group for MPN.骨髓增殖性肿瘤（MPN）患者在新冠疫情期间面临的挑战：德国MPN研究小组患者调查的初步结果
Leuk Res. 2021 Nov;110:106646. doi: 10.1016/j.leukres.2021.106646. Epub 2021 Jun 16.
6
High Level of Circulating Microparticles in Patients with BCR/ABL Negative Myeloproliferative Neoplasm - a Pilot Study.BCR/ABL阴性骨髓增殖性肿瘤患者循环微颗粒水平升高——一项初步研究
Klin Onkol. 2019 Spring;32(2):109-116. doi: 10.14735/amko2019109.
7
Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physicians.费城染色体阴性骨髓增殖性肿瘤（MPN）患者的医疗环境与严重程度、症状负担及并发症：大学医院、社区医院和门诊医生之间的比较
Ann Hematol. 2016 Sep;95(9):1399-410. doi: 10.1007/s00277-016-2730-y. Epub 2016 Jun 22.
8
Developing the Pediatric Refractory Epilepsy Questionnaire: a pilot study.编制儿童难治性癫痫问卷：一项试点研究。
Epilepsy Behav. 2014 Aug;37:26-31. doi: 10.1016/j.yebeh.2014.04.025. Epub 2014 Jun 23.
9
The Inflammatory Bowel Disease Symptom Inventory: A Patient-report Scale for Research and Clinical Application.炎症性肠病症状量表：一种用于研究和临床应用的患者报告量表。
Inflamm Bowel Dis. 2019 Jul 17;25(8):1277-1290. doi: 10.1093/ibd/izz038.
10
Piloting a new patient-related outcome tool to assess cosmetic outcome in Mohs Micrographic surgery.
J Eur Acad Dermatol Venereol. 2017 Oct;31(10):e455-e457. doi: 10.1111/jdv.14270. Epub 2017 May 2.
引用本文的文献
1
Time to Rethink Bronchiolitis Obliterans Syndrome Following Lung or Hematopoietic Cell Transplantation in Pediatric Patients.是时候重新思考小儿患者肺或造血细胞移植后的闭塞性细支气管炎综合征了。
Cancers (Basel). 2024 Nov 4;16(21):3715. doi: 10.3390/cancers16213715.
2
Blood hypercoagulability and thrombosis mechanisms in cancer patients -A brief review.癌症患者的血液高凝性与血栓形成机制——简要综述
Heliyon. 2024 Oct 1;10(19):e38831. doi: 10.1016/j.heliyon.2024.e38831. eCollection 2024 Oct 15.
3
Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives.骨髓纤维化的流行病学及疾病特征：意大利与全球视角的比较分析
Front Oncol. 2024 Jul 24;14:1382872. doi: 10.3389/fonc.2024.1382872. eCollection 2024.
4
Risk of hepatitis B reactivation in patients with myeloproliferative neoplasms treated with ruxolitinib.接受鲁索替尼治疗的骨髓增殖性肿瘤患者发生乙型肝炎病毒再激活的风险。
World J Hepatol. 2023 Nov 27;15(11):1188-1195. doi: 10.4254/wjh.v15.i11.1188.
5
Cytoreductive treatment in real life: a chart review analysis on 1440 patients with polycythemia vera.真实生活中的细胞减灭治疗：1440 例真性红细胞增多症患者的图表回顾性分析。
J Cancer Res Clin Oncol. 2022 Oct;148(10):2693-2705. doi: 10.1007/s00432-021-03855-5. Epub 2021 Nov 22.
6
Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future Scenarios.新冠疫情期间的费城染色体阴性慢性骨髓增殖性肿瘤：挑战与未来展望
Cancers (Basel). 2021 Sep 23;13(19):4750. doi: 10.3390/cancers13194750.
7
The immune landscape in BCR-ABL negative myeloproliferative neoplasms: inflammation, infections and opportunities for immunotherapy.BCR-ABL 阴性骨髓增殖性肿瘤中的免疫景观：炎症、感染和免疫治疗机会。
Br J Haematol. 2022 Mar;196(5):1149-1158. doi: 10.1111/bjh.17850. Epub 2021 Oct 7.
8
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms.单剂量BNT162b2 mRNA新冠疫苗可在骨髓增殖性肿瘤患者中诱导出高频率的中和抗体及多功能T细胞反应。
Leukemia. 2021 Dec;35(12):3573-3577. doi: 10.1038/s41375-021-01300-7. Epub 2021 May 22.
9
Risk of infection in MPN patients in the era of Covid-19: A prospective multicenter study of 257 patients from the CML-MPN Quebec Research Group.新冠疫情时代骨髓增殖性肿瘤患者的感染风险：来自魁北克慢性粒细胞白血病-骨髓增殖性肿瘤研究组的257例患者的前瞻性多中心研究。
Am J Hematol. 2021 Jun 1;96(6):E200-E203. doi: 10.1002/ajh.26159. Epub 2021 Mar 26.
10
COVID-19: High-JAKing of the Inflammatory "Flight" by Ruxolitinib to Avoid the Cytokine Storm.新冠病毒肺炎：芦可替尼对炎症“逃逸”的高度抑制以避免细胞因子风暴
Front Oncol. 2021 Jan 8;10:599502. doi: 10.3389/fonc.2020.599502. eCollection 2020.
Zotero 插件